http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101468525-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2323-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-406
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-34
filingDate 2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101468525-B1
titleOfInvention Oligosiloxane-modified liquid crystal formulations and devices using same
abstract Liquid crystal formulations are described. The liquid crystal formulation comprises a first oligosiloxane-modified nano-phase separation liquid crystal material; And at least one additional material selected from a second oligosiloxane-modified nano-phase separation liquid crystal material, a non-liquid crystalline oligosiloxane-modified material, an organic liquid crystal material, or a non-liquid crystal material, to while having the SmC * temperature range from about 35 ℃ I → SmA * → SmC * has a phase transition, has an inclination angle of about 22.5 ° ± 6 ° or approximately 45 ° ± 6 °, the spontaneous polarization of less than about 50nC / ㎠ And a rotational viscosity of less than about 600 cP. Devices containing the liquid crystal formulations are also described. The device has a stable north shelf geometry, bistable switching and isothermal field alignment, a response time of less than 500 μs and an electric drive field of less than about 30 V / μm when switched between two stable states.
priorityDate 2007-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6294109-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5942155-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414012539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458433298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID593578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414284734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415845215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412075612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448751271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57448840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396227

Total number of triples: 35.